Publication | Closed Access

Early introduction of HMG-CoA reductase inhibitors could prevent the incidence of transplant coronary artery disease

Hmg-coa Reductase InhibitorsTransplantationCardiovascular DiseaseAtherosclerosisPharmacologyCardiovascular PharmacologyPreventive CardiologyMedicineCardiologyEarly IntroductionCoronary Artery DiseaseMyocardial Infarction